Advertisement
Case report| Volume 22, ISSUE 6, P762-766, June 1987

Combined alprazolam and phenelzine treatment of refractory depression with panic attacks

  • Raymond F. Deicken
    Correspondence
    Address reprint requests to Dr. Raymond F. Deicken, Langley Porter Neuropsychiatric Institute, University of California, San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143.
    Affiliations
    From the Department of Psychiatry, University of California, San Francisco School of Medicine, San Francisco, CA USA
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(87)90208-3
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks
Previous ArticleHuntington's disease: Correlations of mental status with chorea
Next ArticleOrganic affective disorder in a patient with congenital adrenal hyperplasia
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Alexander PE
        • Alexander DD
        Alprazolam treatment for panic disorders.
        J Clin Psychiatry. 1986; 47: 301-304
        • Beck AT
        • Ward CH
        • Mendelson M
        • et al.
        An inventory for measuring depression.
        Arch Gen Psychiatry. 1961; 4: 561-571
        • Charney DS
        • Heninger GR
        Noradrenergic function and the mechanism of action of an-tianxiety treatment.
        Arch Gen Psychiatry. 1985; 42: 458-467
        • Charney DS
        • Heninger GR
        Serotonin function in panic disorders: The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.
        Arch Gen Psychiatry. 1986; 43: 1059-1065
        • Chouinard G
        • Annable L
        • Fontaine R
        • Solyom L
        Alprazolam in the treatment of generalized anxiety and panic disorders: A double blind placebo controlled study.
        Psychopharmacology. 1982; 77: 229-233
        • Feighner JP
        • Aden GC
        • Fabre LF
        • et al.
        Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
        JAMA. 1983; 249: 3057-3064
        • Gilman AG
        G proteins and dual control of adenylate cyclase.
        Cell. 1984; 36: 577-579
        • Grunhaus L
        • Rabin D
        • Greden JF
        Simultaneous panic and depressive disorder: Response to antidepressant treatments.
        J Clin Psychiatry. 1986; 47: 4-7
        • Hamilton M
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Lesser IM
        • Rubin RT
        Diagnostic considerations in panic disorders.
        J Clin Psychiatry. 1986; 47: 4-10
        • Liebowitz MR
        • Quitkin FM
        • Steward JW
        • et al.
        Effect of panic attacks on the treatment of atypical depressives.
        Psychopharmacol Bull. 1985; 21: 558-561
        • Mooney JJ
        • Schatzberg AF
        • Cole JO
        • et al.
        Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: Preliminary data.
        J Psychiatr Res. 1985; 19: 65-75
        • Murphy DL
        • Garrick NA
        • Aulakh CS
        • Cohen RM
        New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
        J Clin Psychiatry. 1984; 45: 37-43
        • Rickels K
        • Feighner JP
        • Smith WT
        Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
        Arch Gen Psychiatry. 1985; 42: 134-141
        • Ries RK
        • Wittkowsky AK
        Synergistic action of alprazolam with tranylcypromine in drugresistant atypical depression with panic attacks.
        Biol Psychiatry. 1986; 21: 522-526
        • Robinson DS
        • Kayser A
        • Corcella J
        • et al.
        Panic attacks in outpatients with depression: Response to antidepressant treatment.
        Psychopharmacol Bull. 1985; 21: 562-566
        • Roy-Byrne PP
        • Uhde TW
        Panic disorder and major depression: Biological relationship.
        Psychopharmacol Bull. 1985; 21: 551-554
        • Sethy VH
        • Hodges DH
        Alprazolam in the biochemical model of depression.
        Biochem Pharmacol. 1982; 31: 3155-3157
        • Sethy VH
        • Hodges DH
        Role of beta-adrenergic receptors in the antidepressant activity of alprazolam.
        Res Commun Chem Pathol Pharmacol. 1982; 36: 329-332
        • Uhde TW
        • Vittone BJ
        • Siever LJ
        • Kaye WH
        • Post RM
        Blunted growth hormone response to clonidine in panic disorder patients.
        Biol Psychiatry. 1986; 21: 1081-1085
        • Van Valkenburg CH
        • Akiskal HS
        • Puzantian V
        • et al.
        Anxious depressions.
        J Affect Dis. 1984; 6: 67-82

      Article info

      Publication history

      Received in revised form: November 18, 1986
      Received: September 22, 1986

      Identification

      DOI: https://doi.org/10.1016/0006-3223(87)90208-3

      Copyright

      © 1987 Society of Biological Psychiatry. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX